- Home
- OSRH vs KZIA Comparison
OSRH vs KZIA Comparison
Compare OSRH & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSRH
- KZIA
- Stock Information
- Founded
- OSRH N/A
- KZIA 1994
- Country
- OSRH United States
- KZIA Australia
- Employees
- OSRH N/A
- KZIA N/A
- Industry
- OSRH
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- OSRH
- KZIA Health Care
- Exchange
- OSRH Nasdaq
- KZIA Nasdaq
- Market Cap
- OSRH 13.2M
- KZIA 11.7M
- IPO Year
- OSRH N/A
- KZIA 1999
- Fundamental
- Price
- OSRH $0.68
- KZIA $7.81
- Analyst Decision
- OSRH
- KZIA Strong Buy
- Analyst Count
- OSRH 0
- KZIA 3
- Target Price
- OSRH N/A
- KZIA $16.00
- AVG Volume (30 Days)
- OSRH 2.0M
- KZIA 95.0K
- Earning Date
- OSRH 11-24-2025
- KZIA 11-14-2025
- Dividend Yield
- OSRH N/A
- KZIA N/A
- EPS Growth
- OSRH N/A
- KZIA N/A
- EPS
- OSRH N/A
- KZIA N/A
- Revenue
- OSRH $104,735.00
- KZIA $1,549,158.00
- Revenue This Year
- OSRH N/A
- KZIA N/A
- Revenue Next Year
- OSRH N/A
- KZIA N/A
- P/E Ratio
- OSRH N/A
- KZIA N/A
- Revenue Growth
- OSRH N/A
- KZIA 248983.08
- 52 Week Low
- OSRH $0.45
- KZIA $2.86
- 52 Week High
- OSRH $13.40
- KZIA $39.05
- Technical
- Relative Strength Index (RSI)
- OSRH 51.44
- KZIA 57.79
- Support Level
- OSRH $0.63
- KZIA $6.51
- Resistance Level
- OSRH $0.82
- KZIA $7.39
- Average True Range (ATR)
- OSRH 0.11
- KZIA 0.44
- MACD
- OSRH 0.01
- KZIA 0.10
- Stochastic Oscillator
- OSRH 38.69
- KZIA 81.25
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.